Boris Bodelle

Dr. Boris Bodelle


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in European Journal of Radiology
Verified
Journal Article
Closed access
Boris BodelleBoris Bodelle
Boris Bodelle
CFConstanze Fischbach
Constanze Fischbach
CBChristian Booz
Christian Booz
IYIbrahim Yel
Ibrahim Yel
CFClaudia Frellesen
Claudia Frellesen
JSJan-Erik Scholtz
Jan-Erik Scholtz

21 November 2013 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
Boris BodelleBoris Bodelle
Boris Bodelle
EKE. Klein
E. Klein
NNNaguib Nagy
Naguib Nagy
RBR.W. Bauer
R.W. Bauer
JKJ.M. Kerl
J.M. Kerl
BSB. Schulz
B. Schulz
BACKGROUND AND PURPOSE: Acute intracranial hemorrhage represents a severe and time critical pathology that requires precise and quick diagnosis, mainly by performing a CT scan. The purpose of this study was to compare image quality and intracranial hemorrhage conspicuity in brain CT with sinogram-affirmed iterative reconstruction and filtered back-projection reconstruction techniques at standard (340 mAs) and low-dose tube current levels (260 mAs). MATERIALS AND METHODS: A total of 94 consecutive patients with intracranial hemorrhage received CT scans either with standard or low-dose protocol by random assignment. Group 1 (n=54; mean age, 64 ± 20 years) received CT at 340 mAs, and group 2 (n=40; mean age, 57 ± 23 years) received CT at 260 mAs. Images of both groups were reconstructed with filtered back-projection reconstruction and 5 iterative strengths (S1–S5) and ranked blind by 2 radiologists for image quality and intracranial hemorrhage on a 5-point scale. Image noise, SNR, dose-length product (mGycm), and mean effective dose (mSv) were calculated. RESULTS: In both groups, image quality and intracranial hemorrhage conspicuity were rated subjectively with an excellent/good image quality. A higher strength of sinogram-affirmed iterative reconstruction showed an increase in image quality with a difference to filtered back-projection reconstruction (P < .05). Subjective rating showed the best score of image quality and intracranial hemorrhage conspicuity achieved through S3/S4–5. Objective analysis of image quality showed in an increase of SNR with a higher strength of sinogram-affirmed iterative reconstruction. Patients in group 2 (mean: 744 mGycm/1.71 mSv) were exposed to a significantly lower dose than those in group 1 (mean: 1045 mGycm/2.40 mSv, P < .01). CONCLUSIONS: S3 provides better image quality and visualization of intracranial hemorrhage in brain CT at 260 mAs. Dose reduction by almost one-third is possible without significant loss in diagnostic quality.

1 July 2015 in Clinical Radiology
Verified
Journal Article
Closed access
Boris BodelleBoris Bodelle
Boris Bodelle
JWJ.L. Wichmann
J.L. Wichmann
NKN. Klotz
N. Klotz
TLT. Lehnert
T. Lehnert
TVT.J. Vogl
T.J. Vogl
BSB. Schulz
B. Schulz

28 March 2017 in Pediatric Radiology
Verified
Journal Article
Closed access
PDF file
Boris BodelleBoris Bodelle
Boris Bodelle
CFConstanze Fischbach
Constanze Fischbach
CBChristian Booz
Christian Booz
IYIbrahim Yel
Ibrahim Yel
CFClaudia Frellesen
Claudia Frellesen
JSJan-Erik Scholtz
Jan-Erik Scholtz

1 October 2015 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
JSJ.-E. Scholtz
J.-E. Scholtz
MKM. Kaup
M. Kaup
KHK. Hüsers
K. Hüsers
MAM.H. Albrecht
M.H. Albrecht
Boris BodelleBoris Bodelle
Boris Bodelle
JWJ.L. Wichmann
J.L. Wichmann
BACKGROUND AND PURPOSE: Dose-saving techniques in neck CT cause increased image noise that can be counteracted by iterative reconstruction. Our aim was to evaluate the image quality of advanced modeled iterative reconstruction (ADMIRE) in contrast-enhanced low-tube-voltage neck CT. MATERIALS AND METHODS: Sixty-one patients underwent 90-kV(peak) neck CT by using third-generation 192-section dual-source CT. Image series were reconstructed with standard filtered back-projection and ADMIRE strength levels 1, 3, and 5. Attenuation and noise of the sternocleidomastoid muscle, internal jugular vein, submandibular gland, tongue, subscapularis muscle, and cervical fat were measured. Signal-to-noise and contrast-to-noise ratios were calculated. Two radiologists assessed image noise, image contrast, delineation of smaller structures, and overall diagnostic acceptability. Interobserver agreement was calculated. RESULTS: Image noise was significantly reduced by using ADMIRE compared with filtered back-projection with the lowest noise observed in ADMIRE 5 (filtered back-projection, 9.4 ± 2.4 Hounsfield units [HU]; ADMIRE 1, 8.3 ± 2.8 HU; ADMIRE 3, 6.7 ± 2.0 HU; ADMIRE 5, 5.4 ± 1.7 HU; all, P < .001). Sternocleidomastoid SNR and internal jugular vein–sternocleidomastoid contrast-to-noise ratios were significantly higher for ADMIRE with the best results in ADMIRE 5 (all, P < .001). Subjective image quality and image contrast of ADMIRE 3 and 5 were consistently rated better than those for filtered back-projection and ADMIRE 1 (all, P < .001). Image noise was rated highest for ADMIRE 5 (all, P < .005). Delineation of smaller structures was voted higher in all ADMIRE strength levels compared with filtered back-projection (P < .001). Global interobserver agreement was good (0.75). CONCLUSIONS: Contrast-enhanced 90-kVp neck CT is feasible, and ADMIRE 5 shows superior objective image quality compared with filtered back-projection. ADMIRE 3 and 5 show the best subjective image quality.

28 February 2020 in Frontiers in Surgery
Verified
Journal Article
Open access
PDF file
MWMike Wenzel
Mike Wenzel
LTLena Theissen
Lena Theissen
FPFelix Preisser
Felix Preisser
BLBenedikt Lauer
Benedikt Lauer
CWClarissa Wittler
Clarissa Wittler
ABAndreas Becker
Andreas Becker
Introduction: There is still an ongoing debate whether a transrectal ultrasound (TRUS) approach for prostate biopsies is associated with higher (infectious) complications rates compared to transperineal biopsies. This is especially of great interests in settings with elevated frequencies of multidrug resistant organisms (MDRO). Materials and Methods: Between 01/2018 and 05/2019 230 patients underwent a TRUS-guided prostate biopsy at the department of Urology at University Hospital Frankfurt. Patients were followed up within the clinical routine that was not conducted earlier than 6 weeks after the biopsy. Among 230 biopsies, 180 patients took part in the follow-up. No patients were excluded. Patients were analyzed retrospectively regarding complications, infections and underlying infectious agents or needed interventions. Results: Of all patients with follow up, 84 patients underwent a systematic biopsy (SB) and 96 a targeted biopsy (TB) after MRI of the prostate with additional SB. 74.8% of the patients were biopsy-naïve. The most frequent objective complications (classified by Clavien-Dindo) lasting longer than one day after biopsy were hematuria (17.9%, n = 32), hematospermia (13.9%, n = 25), rectal bleeding (2.8%, n = 5), and pain (2.2%, n = 4). Besides a known high MDRO prevalence in the Rhine-Main region, only one patient (0.6%) developed fever after biopsy. One patient each (0.6%) consulted a physician due to urinary retention, rectal bleeding or gross hematuria. There were no significant differences in complications seen between SB and SB + TB patients. The rate of patients who consulted a physician was significantly higher for patients with one or more prior biopsies compared to biopsy-naïve patients. Conclusion: Complications after transrectal prostate biopsies are rare and often self-limiting. Infections were seen in <1% of all patients, regardless of an elevated local prevalence of MDROs. Severe complications (Clavien-Dindo ≥ IIIa) were only seen in 3 (1.7%) of the patients. Repeated biopsy is associated with higher complication rates in general.